Targeted Next-Generation Sequencing in Myelodysplastic Syndromes and Prognostic Interaction Between Mutations and IPSS-R

American Journal of Hematology - United States
doi 10.1002/ajh.24901
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Targeted Next-Generation Sequencing Is a Sensitive Tool for Differential Diagnosis of Myelodysplastic Syndromes in Bone Marrow Trephines

Journal of Molecular Diagnostics
Forensic MedicinePathologyMolecular Medicine
2018English

Mapping Actionable Pathways and Mutations in Brain Tumours Using Targeted RNA Next Generation Sequencing

Acta neuropathologica communications
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2019English

Prognostic Impact of IPSS-R and Chromosomal Translocations in 751 Korean Patients With Primary Myelodysplastic Syndrome

PLoS ONE
Multidisciplinary
2016English

Prognostic Significance of U2AF1 Mutations in Myelodysplastic Syndromes: A Meta-Analysis

Journal of International Medical Research
BiochemistryMedicineCell Biology
2019English

Cytogenetic Prognostic Factors in Myelodysplastic Syndromes

Hematology & blood transfusion: interdepartamental collection
2016English

What Role Can Next-Generation Sequencing Play in Myelodysplastic Syndrome Care?

Expert Review of Hematology
Hematology
2019English

Targeted Therapy According to Next Generation Sequencing-Based Panel Sequencing

Fukushima Journal of Medical Sciences
Medicine
2018English

Targeted Next Generation Sequencing Identifies Two Novel Mutations in SEPN1 in Rigid Spine Muscular Dystrophy 1

Oncotarget
Oncology
2016English

Prognosis of Patients With Intermediate Risk IPSS-R Myelodysplastic Syndrome Indicates Variable Outcomes and Need for Models Beyond IPSS-R

American Journal of Hematology
Hematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy